AMARNA HOLDING B V has a total of 14 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Canada, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ALPHAVAX INC, COSMA MARIA PIA and S BIOMEDICS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 2 | |
#4 | Brazil | 1 | |
#5 | EAPO (Eurasian Patent Organization) | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 | |
#8 | United States | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Vries De Walter Gerhardus | 7 |
#2 | De Haan Petrus Theodorus | 3 |
#3 | Haan De Petrus Theodorus | 2 |
#4 | Vries Walter Gerhardus De | 1 |
#5 | Walter Gerhardus De Vries | 1 |
Publication | Filing date | Title |
---|---|---|
EP3071224A1 | Method for restoring immune tolerance in vivo | |
EP2494057A1 | Method for the expression of a recombinant protein in a mammalian cell | |
KR20120006062A | Method for the production of recombinant polyomaviral vector particles |